Will Oura's market cap be between $12.5B and $15B at market close on IPO day?

As of August 21, 2026, Polymarket prices “Will Oura's market cap be between $12.5B and $15B at market close on IPO day?” at 10% YES with $74K traded. No tracked wallet holds a position on this market, so there is no verdict.

Prediction markets put the probability at 10%: Will Oura's market cap be between $12.5B and $15B at market close on IPO day. Currently, markets see this as unlikely (10% YES).

What’s Happening

Oura’s confidential IPO filing with the U.S. Securities and Exchange Commission on May 21, 2026 sets the stage for a public market debut that will test whether the smart ring maker can justify a valuation range of $12.5B to $15B at market close on IPO day. The company’s last private funding round in October 2025—a $900 million investment—valued Oura at approximately $11 billion, meaning the upper bound of the current market scenario implies a 36% premium over that figure. Oura reported more than four times revenue growth over the past two fiscal years, reinvesting gross profit into product development and healthcare feature expansion, according to its filing announcement. [MobiHealthNews, May 22]

The market’s current 10% probability that Oura’s market cap will land between $12.5B and $15B at IPO close reflects investor caution about wearable hardware valuations, which have historically traded at 3-5x forward revenue multiples. Oura’s trajectory—on pace to surpass 5 million paid members in Q2 2026—suggests annualized revenue potentially exceeding $600 million, which would place a $15B valuation at roughly 25x trailing revenue, a steep premium compared to peers like Garmin (approximately 4x) and Apple (approximately 8x). The company’s recent C-suite expansion, including its first Chief Information Officer and a Senior VP of AI hired in August 2026, signals preparation for public market scrutiny of operational scalability. [WSJ, May 21]

The IPO pricing window will likely open in late Q4 2026, with Oura’s draft registration statement still under SEC review. Key indicators to watch include the 10-year Treasury yield (currently 4.567%) and broader tech IPO performance, as rising rates have compressed growth stock multiples by 15-20% since early 2025. Oura’s healthcare push—expanding from sleep tracking to clinical-grade temperature and heart rate monitoring—could justify a higher multiple if the company demonstrates reimbursement pathways or partnerships with health systems. The MedTech Dive report notes the filing follows a period of aggressive investment in health features, positioning Oura as a medical device play rather than a pure consumer gadget maker. If the company prices below $12.5B, it would signal that private market optimism has not translated to public market demand; if it exceeds $15B, it would mark one of the largest wearable IPOs since Fitbit’s 2015 debut. [MedTech Dive, May 26]

Traded on Polymarket — $74K Volume